We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

42 hedge funds and large institutions have $4.68M invested in Abeona Therapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

0.32% less ownership

Funds ownership: 0.89% → 0.57% (-0.32%)

22% less funds holding

Funds holding: 54 → 42 (-12)

55% less capital invested

Capital invested by funds: $10.5M → $4.68M (-$5.77M)

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

Holders
42
Holders Change
-12
Holders Change %
-22.22%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
7
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$15K
3
Renaissance Technologies
Renaissance Technologies
New York
+$14.6K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.98K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.97K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$1.58M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.01M
3
WVP
Worth Venture Partners
New Jersey
-$245K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$163K
5
Franklin Resources
Franklin Resources
California
-$102K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$7K +$7.24K +1,432 +2,170%
EGM
27
Engineers Gate Manager
New York
$5K – – –
HFM
28
Hartford Financial Management
Connecticut
$4K – – –
SW
29
SVB Wealth
Massachusetts
$4K – – –
Victory Capital Management
30
Victory Capital Management
Texas
$4K +$152 +30 +4%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$3K -$5.2K -1,028 -65%
WA
32
WealthTrust Axiom
Pennsylvania
$3K – – –
Squarepoint
33
Squarepoint
New York
$3K +$390 +77 +16%
MML Investors Services
34
MML Investors Services
Massachusetts
$2K – – –
PA
35
Parallel Advisors
California
$2K – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$25 – – –
BRWM
37
B. Riley Wealth Management
Tennessee
$3 +$2.61K +516 New
ACM
38
AIGH Capital Management
Maryland
– -$1.58M -201,004 Closed
Point72 Asset Management
39
Point72 Asset Management
Connecticut
– -$1.01M -128,000 Closed
Franklin Resources
40
Franklin Resources
California
– -$102K -13,000 Closed
Assenagon Asset Management
41
Assenagon Asset Management
Luxembourg
– -$69K -8,783 Closed
HF
42
HRT Financial
New York
– -$31K -3,962 Closed
Citadel Advisors
43
Citadel Advisors
Florida
– -$29K -3,759 Closed
Citigroup
44
Citigroup
New York
– -$27K -3,477 Closed
MIFH
45
Migdal Insurance & Financial Holdings
Israel
– -$24K -3,100 Closed
SWP
46
Stratos Wealth Partners
Ohio
– -$13K -1,600 Closed
TSS
47
Two Sigma Securities
New York
– -$9K -1,084 Closed
WAM
48
Warberg Asset Management
Illinois
– -$7K -893 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$1.36K -268 -95%
MCC
50
Money Concepts Capital
Florida
– -$2K -200 Closed
1
2
3

ABEO Hedge Fund Activity: Q2 2022 in Review

42 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2022, worth a combined $4.68M — down 55% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ABEO and 2 opened new positions — a net loss of 12 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was State Street, adding an estimated $15.1K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.58M sold.

  • 42 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2022, down from 54 in Q1 2022.
  • Funds reported $4.68M of Abeona Therapeutics stock for Q2 2022, down 55% quarter-over-quarter.
  • 2 funds opened new Abeona Therapeutics positions in Q2 2022 and 14 closed out, a net change of -12 holders.
  • The largest Abeona Therapeutics buyer in Q2 2022 was State Street, an estimated $15.1K added.
  • The largest Abeona Therapeutics seller in Q2 2022 was AIGH Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q2 2022.